Aetna Clinical Policy Bulletin No 0469. Transcranial Magnetic Stimulation and Cranial Electrical Stimulation, http://www.aetna.com. Accessed 04/18/2011.
AHRQ: Nonpharmacologic Interventions for Treatment- Resistant Depression - 9/23/2011. http:// www.effectivehealthcare.ahrq.gov/index.cfm/ search-for-guides-reviews-and-reports/?productid=787 &pageaction=displayproduct (Date accessed 7/10/12)
American Psychiatric Association (2010). http://www.psychiatryonline.com/pracGuide/pracGuideTopic_7.aspx (Date accessed 7/10/12)
Avery DH, Isenberg KE, Sampson SM, et al. Transcranial magnetic stimulation in the acute treatment of major depression: clinical response in an open-label extension trial. J Clin Psychiatry 2008; 69(3):441-451.
Blue Cross Blue Shield Association (BCBSA). Technology Evaluation Center (TEC). Transcranial magnetic stimulation for depression. TEC Assessments in Press. April 2011.
Blue Cross Blue Shield Association (BCBSA). Technology Evaluation Center (TEC). Transcranial magnetic stimulation for depression. TEC Assessment Program. Chicago, IL:BCBSA. 2009:24(5).
Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol. 2002; 5:73–103.
Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial Magnetic Stimulation (TMS) for Major Depression: A Multisite, Naturalistic, Observation Study of Acute Treatment Outcomes in Clinical Practice Depression and Anxiety. 2012;29:587-596.
Chen R. Repetitive transcranial magnetic stimulation as treatment for depression in Parkinson’s disease. Movement Disorders 2010;25(14):2272-2273.
CIGNA Medical Policy - Transcranial Magnetic Stimulation - updated 01/15/2011.
Clinical Trials Search of Transcranial Magnetic Stimulation/Depression found 9 new studies with 8 recruiting patients and 1 study not yet recruiting. http:// www.clinicaltrials.gov/ct2/results?term=Transcranial+Magnetic+Stimulation &recr=&rslt. Accessed 04/26/2011.
Conolly RK, Helmer A, Cristancho MA, et al. Effectiveness of TMS in Clinical Practice Post FDA-approval in the United States: Results Observed with the First 100 Consecutive Cases of Depression at an Academic Medical Center. Journal of Clinical Psychiatry 2012 April;73(4)e567-573.
Couturier JL. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci 2005; 30:83–90.
Croarkin PE, Wall CA, McClintock SM, et al. The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression. Journal of ECT 2010;26(4):323-329.
Dannon PN, Dolberg OT, Schreiber S, et al. Three and six-month outcome following courses of either ECT or rTMS in a population of severely depressed individuals—preliminary report. Biol Psychiatry. 2002; 51:687–690.
Daskalakis ZJ, Levinson AJ, Fitzgerald PB. Repetitive transcranial magnetic stimulation for major depressive disorder. A review. Can J Psychiatry. 2008; 53(9):555-566.
Demitrack MA, Thase ME. Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: A Review and Synthesis of Recent Data. 2009 Psychopharmacology Bulletin, 42(2):5-38.
Dunner DL, Aaronson ST, Sackeim HA, et al. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry. 2014 Dec;75(12):1394-401.
Eranti S, Mogg A, Pluck G, et al. A Randomized, Controlled Trial with 6 Month Follow-up of Repetitive Transcranial Magnetic Stimulation and Electroconvulsive Therapy for Severe Depression. Am J Psychiatry 2007; 164(1):73-81.
Fitzgerald PB, Grace N, Hoy KE, et al. An Open Label Trial of Clustered Maintenance rTMS for Patients with Refractory Depression. Brain Stimulation 2013;6(3):292-297.
Fregni F, Marcolin MA, Myczkowski M, et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol. 2006; 9:641–654.
Gaynes BN, Lux LJ, Lloyd SW, et al. Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults. Comparative Effectiveness Review, Number 33. Agency for Healthcare Research and Quality (AHRQ); September 2011.Publication #11-EHC056-EF. Last accessed on 07/10/2017 at https:// www.effectivehealthcare.ahrq.gov /ehc/products/76/792/TRD_CER33_20111110.pdf
Gelenberg AJ, Freeman MP, Markowitz JC, et al. Practice Guideline for the Treatment of Patients with Major Depressive Disorder. American Psychiatric Association. Third Edition. Published October 2010. Last accessed on 07/10/2017 at https:// psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines /guidelines/mdd.pdf
George MS. Transcranial magnetic stimulation for the treatment of depression. Expert Rev. Neurother 2010;10(11):1761-1772.
George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder. A sham-controlled randomized trial. Arch Gen Psychiatry 2010; 60(5)507-516.
George MS, Schlaepfer T, Padberg F, et al. Brain stimulation treatments for depression. World J Biol Psychiatry. 2014 Feb;15(2):167-8.
Gross, M, Nakamura L, Pascual-Leone A, et al. Has Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Depression Improved? A systematic Review and Meta-analysis Comparing the Recent vs. The Earlier rTMS Studies. Acta Psychiatr Scand.2007; 116(3): 165-173.
Hayes Inc. Evaluating the efficacy of transcranial magnetic stimulation to treat major depression. Hayes Overview. Lansdale, PA; Hayes, May 25, 2010.
Herbsman T, Avery D, Ramsey D, et al. More Lateral and Anterior Prefrontal Coil Location is Associated with Better Repetitive Transcranial Magnetic Stimulation Antidepressant Response. Biol Psychiatry 2009; 66(5):509-15.
Herbsman T, Forster L, Molnar C, et al. Motor Threshold in Transcranial Magnetic Stimulation: The Impact of White Matter Fiber Orientation and Skull-to-Cortex Distance. Hum Brain Mapp. 2009;30(7):2044-2055.
Herrmann LL, Ebmeier KP. Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J Clin Psychiatry. 2006; 67:1870–1876.
Herwig U, Fallgatter AJ, Hoppner J, et al. Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial. Br J Psychiatry. 2007; 191:441–448.
Herwig U, Padberg F, Unger J.et al. Transcranial magnetic stimulation in therapy studies: examination of the reliability of "standard" coil positioning by neuronavigation. Biol Psychiatry 2001; 50(1):58-61.
Holtzheimer PE, McDonald WM, Mutfi M, et al. Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depression and Anxiety 2010;27:960-963.
Horvath JC, Mathews J, Demitrack MA, et al. The Neurostar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression. J. Vis. Exp. 2010; (45), e2345.
Institute of Clinical and Economic Review (2011). Nonpharmacologic Interventions for Treatment-Resistant Depression: Supplementary Data and Analyses to the Comparative Effectiveness Review of the Agency for Healthcare Research and Quality. Boston, MA: http:// cepac.icer-review.org/wp-content/uploads/2012/01/ Final-Report-TRD_FINAL1.pdf (Date accessed 7/10/12).
Janicak PG, Dowd SM, Martis B, et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial. Biol Psychiatry. 2002; 51:659–667.
Janicak PG, Dunner DL, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice. CNS Spectr. 2013 Dec;18(6):322-32.
Janicak PG, Nahas Z, Lisanby SH, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul. 2010 Oct;3(4):187-99.
Janicak PG, O’Reardon JP, Sampson SM, et al. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J Clin Psychiatry. 2008 Feb;69(2):222-32.
Jorge RE, Moser DJ, Acion L, et al. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry. 2008; 65:268–276.
Kozel FA, George MS. Meta-Analysis of Left Prefrontal Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat Depression. J Psychiatr Pract. 2002; 8:270–275.
Lam RW, Chan P, Wilkins-Ho M, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry 2008; 53:621-631.
Levkovitz Y, Isserles M, Padberg F, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry. 2015 Feb; 14(1): 64–73.
Lisanby SH, Husain MM, Rosenquist PB, et al. Daily Left Prefrontal Repetitive Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: Clinical Predictors of Outcome in a Multisite, Randomized Controlled Clinical Trial. Neuropsychopharmacology. 2009; 34(2): 522-34.
Mantovani A, Pavlicova M, Avery D, et al. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. Depress Anxiety. 2012 Oct;29(10):883-90.
Mark DH, Aronson N, Ziegler KM, et al. Transcranial Magnetic Stimulation for Depression. Tec Assessment Program October 2009;24(5).
Martin JL, Barbanoj MJ, Schlaepfer TE, et al. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry 2003;182:480-491.
Martin JL, Barbanoj MJ, Schlaepfer TE, et al. Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev. 2002; CD003493.
McDonald WM, Durkalski V, Ball ER, et al. Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety. 2011 Nov;28(11):973-80.
O’Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62(11):1208-1216.
O’Reardon J, Altinay M, Cristancho P. Transcranial Magnetic Stimulation: A New Treatment Option for Major Depression. Psychiatric Times. September 2010. https:// www.cmellc.com/CMEActivities/tabid/54/ctl/ ActivityController/mid/545/activityid/2009/Default.aspx (Date accessed 7/10/12)
Perera T, George MS, Grammer G, et al. The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder. Brain Stimul. 2016; 9(3):336-46.
Pridmore S. Substitution of rapid transcranial magnetic stimulation treatments for electroconvulsive therapy treatments in a course of electroconvulsive therapy. Depress Anxiety. 2000; 12:118–123.
Rodriguez-Martin JL, Barbanoj JM, Schlaepfer TE, et al. Transcranial magnetic stimulation for treating depression. Cochrane Database of Systematic Reviews 2001, Issue 4. Art. No.: CD003493.
Rosa MA, Gattaz WF, Pascual-Leone A, et al. Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic refractory depression: a randomized, single-blind study. Int J Neuropsychopharmacol. 2006; 9:667–676.
Rosenberg O, Zangen A, Stryjer R, et al. Response to deep TMS in depressive patients with previous electroconvulsive treatment. Brain Stimulation 2010; 3:211-217.
Rossi S, Hallett M, Rossini PM, et al. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009; 120(12):2008-2039.
Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one of several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11) 1905-1917.
Schulze-Rauschenbach SC, Harms U, Schlaepfer TE, et al. Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression. Br J Psychiatry. 2005; 186:410–416.
Schutter DJ. Antidepressant efficacy of high frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham controlled designs: a meta-analysis. Psychol Med 2009; 39:65-75.
Slotema CW, Blom JD, Hoek HW, et al. Should We Expand the Toolbox of Psychiatric Treatment Methods to Include Repetitive Transcranial Magnetic Stimulation (rTMS)? A Meta-analysis of the Efficacy of rTMS in Psychiatric Disorders. Journal of Clinical Psychiatry. 2010; 71(7):873-884.
The Regance Group. Medical Policy - Transcranial Magnetic Stimulation as a Treatment of Depression and Other Disorders. Policy No. 17. Updated 03/01/2011.
UnitedHealthCare Medical Policy 2011T0536B effective January 1, 2011. Transcranial Magnetic Stimulation. https://www.unitedhealthcareonline.com. Accessed 04/28/2011.
U.S. Food and Drug Administration (2007) Neurological Devices Panel of the Medical Devices Advisory Committee. January 26, 2007. FDA Executive Summary.
Wellpoint Medical Policy BEH.00002. Transcranial Magnetic Stimulation for Depression and Other Neuropsychiatric Disorders. Last Review Date: 11/18/2010.
Westin GG, Bassi BD, Lisanby SH, et al. Determination of motor threshold using visual observation overestimates transcranial magnetic stimulation dosage: Safety implications. Clin Neurophysiol. 2014; 125(1):142-147.
Other Contractor's Policies
Contractor Medical Directors